Cookson Peirce & Co’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Buy
8,977
+314
+4% +$41.4K 0.04% 203
2026
Q1
$1.21M Sell
8,663
-2,612
-23% -$366K 0.05% 175
2025
Q4
$1.38M Buy
11,275
+1,230
+12% +$149K 0.06% 148
2025
Q3
$1.11M Buy
10,045
+7,168
+249% +$815K 0.05% 161
2025
Q2
$319K Buy
+2,877
New +$306K 0.01% 239

Other funds holding GILD

Cookson Peirce & Co's GILD Position: Q2 2026 in Review

Cookson Peirce & Co increased its Gilead Sciences (GILD) stake by 3.6% in Q2 2026, buying an estimated $41.4K and bringing the position to 8,977 shares worth $1.13M. The position accounts for 0.04% of the portfolio, ranked #203.

Cookson Peirce & Co first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.38M in Q4 2025. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cookson Peirce & Co held 8,977 shares of Gilead Sciences worth $1.13M as of Q2 2026.
  • Cookson Peirce & Co bought 314 Gilead Sciences shares in Q2 2026, an estimated $41.4K.
  • Gilead Sciences made up 0.04% of Cookson Peirce & Co's portfolio in Q2 2026, its #203 holding.
  • Cookson Peirce & Co first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Cookson Peirce & Co's Gilead Sciences position peaked at $1.38M in Q4 2025.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.